Truist lowered the firm’s price target on Edgewell Personal Care (EPC) to $35 from $40 as a result of recent multiple compression across CPG companies, while keeping a Buy rating on the shares following quarterly results. The firm is also lowering its FY25 sales, adjusted EPS, and adjusted EBITDA estimates to $2.247B, $3.16, and $357.0M, respectively, from $2.314B, $3.25, and $361.8M. Additionally, Truist is lowering its FY26 sales, adjusted EPS, and adjusted EBITDA estimates of $2.304B, $3.37, and $374.4M, respectively, from $2.371B, $3.46, and $380.4M.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care price target lowered to $43 from $48 at RBC Capital
- Edgewell Personal Care price target lowered to $40 from $53 at Canaccord
- Edgewell Personal Care price target lowered to $32 from $35 at Morgan Stanley
- Edgewell Personal Care price target lowered to $35 from $37 at Wells Fargo
- Edgewell Personal Care: Attractive Buy Rating Amidst Low Valuation and Future Growth Prospects